LEUKEMIA ACUTE MYELOID - AML

Clinical trials for LEUKEMIA ACUTE MYELOID - AML explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA ACUTE MYELOID - AML trials appear

Sign up with your email to follow new studies for LEUKEMIA ACUTE MYELOID - AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

Early trial aims to boost leukemia treatment with added immune drug

Disease control Not yet recruiting

This early-stage study is testing whether adding the drug tocilizumab to a standard two-drug chemotherapy regimen is safe and tolerable for adults with acute myeloid leukemia (AML) who cannot receive intensive treatment. Researchers will gradually increase the dose of tocilizumab…

Matched conditions: LEUKEMIA ACUTE MYELOID - AML

Phase: PHASE1 • Sponsor: Nantes University Hospital • Aim: Disease control

Last updated Apr 02, 2026 15:00 UTC

LEUKEMIA ACUTE MYELOID - AML

Get alerted when new LEUKEMIA ACUTE MYELOID - AML trials appear

Early trial aims to boost leukemia treatment with added immune drug